SCHEMBL17008348

SCHEMBL17008348

CC(C)(C)[Si](OC1CCCC(O)(CO)C1)(c1ccccc1)c1ccccc1

nearest known ligand 0.38

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
BACE1 P56817 1/20 0.38
TRPA1 O75762 1/20 0.35
SMYD2 Q9NRG4 2/20 0.31
CYP3A4 P08684 1/20 0.31
HTT P42858 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21827648 0.79 BACE1 (0.41) BACE1TRPA1SMYD2CYP3A4HTT
SCHEMBL29498916 0.77 BACE1 (0.42) BACE1SMYD2CYP3A4HTTSMN1; SMN2
SCHEMBL26466340 0.76 BACE1 (0.41) BACE1CYP3A4HTTSMN1; SMN2
SCHEMBL5188479 0.75 BACE1 (0.41) BACE1SMYD2CYP3A4HTTSMN1; SMN2
SCHEMBL3397502 0.75 BACE1 (0.39) BACE1
SCHEMBL3401741 0.75 BACE1 (0.39) BACE1
SCHEMBL26098850 0.74 BACE1 (0.42) BACE1
SCHEMBL27221151 0.74 BACE1 (0.36) BACE1TRPA1CYP3A4HTTSMN1; SMN2
SCHEMBL27232767 0.74 BACE1 (0.36) BACE1TRPA1CYP3A4HTTSMN1; SMN2
SCHEMBL31527116 0.74 CYP3A4 (0.35) BACE1SMYD2CYP3A4HTTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220017559-A1 CYCLIC PEROXIDES AS PRODRUGS FOR SELECTIVE DELIVERY OF AGENTS THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 2022-01-20 US disclosed
US-11014955-B2 Cyclic peroxides as prodrugs for selective delivery of agents THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2021-05-25 US disclosed
US-20200317714-A1 CYCLIC PEROXIDES AS PRODRUGS FOR SELECTIVE DELIVERY OF AGENTS THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 2020-10-08 US disclosed
US-10662215-B2 Cyclic peroxides as prodrugs for selective delivery of agents THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2020-05-26 US disclosed
US-20190284224-A1 CYCLIC PEROXIDES AS PRODRUGS FOR SELECTIVE DELIVERY OF AGENTS THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 2019-09-19 US disclosed
US-10287312-B2 Cyclic peroxides as prodrugs for selective delivery of agents THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2019-05-14 US disclosed
EP-3104857-A1 CYCLIC PEROXIDES AS PRODRUGS FOR SELECTIVE DELIVERY OF AGENTS The Regents of The University of California (US) 2016-12-21 EP disclosed
US-20160362439-A1 CYCLIC PEROXIDES AS PRODRUGS FOR SELECTIVE DELIVERY OF AGENTS THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 2016-12-15 US disclosed
US-20160362439-A1 CYCLIC PEROXIDES AS PRODRUGS FOR SELECTIVE DELIVERY OF AGENTS THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 2016-12-15 US disclosed
WO-2015123595-A1 CYCLIC PEROXIDES AS PRODRUGS FOR SELECTIVE DELIVERY OF AGENTS THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2015-08-20 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10662215-B2 Cyclic peroxides as prodrugs for selective delivery of agents GPX4, PRDX1, PRDX3 BACE1 3135/4885TRPA1 1820/4885SMYD2 4364/4885
US-11014955-B2 Cyclic peroxides as prodrugs for selective delivery of agents GPX4, PRDX1, PRDX3 BACE1 3135/4885TRPA1 1820/4885SMYD2 4364/4885
US-20190284224-A1 CYCLIC PEROXIDES AS PRODRUGS FOR SELECTIVE DELIVERY OF AGENTS GPX4, PRDX1, PRDX3 BACE1 3135/4885TRPA1 1820/4885SMYD2 4364/4885
US-20220017559-A1 CYCLIC PEROXIDES AS PRODRUGS FOR SELECTIVE DELIVERY OF AGENTS GPX4, PRDX1, PRDX3 BACE1 3135/4885TRPA1 1820/4885SMYD2 4364/4885
US-20160362439-A1 CYCLIC PEROXIDES AS PRODRUGS FOR SELECTIVE DELIVERY OF AGENTS GPX4, PRDX1, PRDX3 BACE1 3135/4885TRPA1 1820/4885SMYD2 4364/4885
US-10287312-B2 Cyclic peroxides as prodrugs for selective delivery of agents GPX4, PRDX1, PRDX3 BACE1 3135/4885TRPA1 1820/4885SMYD2 4364/4885
US-20200317714-A1 CYCLIC PEROXIDES AS PRODRUGS FOR SELECTIVE DELIVERY OF AGENTS GPX4, PRDX1, GPX1 BACE1 2975/4885TRPA1 1788/4885SMYD2 4181/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.